BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36566018)

  • 1. SGOL2 promotes prostate cancer progression by inhibiting RAB1A ubiquitination.
    Lv T; He D; Zhang X; Guo X; Li Z; Zhang A; Fan B; Wang Z
    Aging (Albany NY); 2022 Dec; 14(24):10050-10066. PubMed ID: 36566018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A.
    Sun T; Wang X; He HH; Sweeney CJ; Liu SX; Brown M; Balk S; Lee GS; Kantoff PW
    Oncogene; 2014 May; 33(21):2790-800. PubMed ID: 23770851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deubiquitinating enzyme PSMD7 promotes bladder cancer development: Involvement of RAB1A stabilization.
    Wang J; Wang T; Feng YK; Liu Y; Fu B; Liu XT; Wu QZ
    Cell Signal; 2024 Feb; 114():110996. PubMed ID: 38040402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of tumor microenvironment by nitric oxide impedes castration-resistant prostate cancer growth.
    Arora H; Panara K; Kuchakulla M; Kulandavelu S; Burnstein KL; Schally AV; Hare JM; Ramasamy R
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11298-11303. PubMed ID: 30322928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone.
    Fradet A; Bouchet M; Delliaux C; Gervais M; Kan C; Benetollo C; Pantano F; Vargas G; Bouazza L; Croset M; Bala Y; Leroy X; Rosol TJ; Rieusset J; Bellahcène A; Castronovo V; Aubin JE; Clézardin P; Duterque-Coquillaud M; Bonnelye E
    Oncotarget; 2016 Nov; 7(47):77071-77086. PubMed ID: 27776343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity.
    Ding G; Wang J; Feng C; Jiang H; Xu J; Ding Q
    Oncotarget; 2016 Sep; 7(39):64309-64317. PubMed ID: 27602760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
    Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
    Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRD4 Regulates Metastatic Potential of Castration-Resistant Prostate Cancer through AHNAK.
    Shafran JS; Andrieu GP; Györffy B; Denis GV
    Mol Cancer Res; 2019 Aug; 17(8):1627-1638. PubMed ID: 31110158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the KIF4A/AR Axis to Reverse Endocrine Therapy Resistance in Castration-resistant Prostate Cancer.
    Cao Q; Song Z; Ruan H; Wang C; Yang X; Bao L; Wang K; Cheng G; Xu T; Xiao W; Xiong Z; Liu D; Yang M; Zhou D; Yang H; Chen K; Zhang X
    Clin Cancer Res; 2020 Mar; 26(6):1516-1528. PubMed ID: 31796514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rab1A promotes cell proliferation and migration by upregulating Gli1 in colorectal cancer.
    Peng C; Li X; Ye Z; Wu W
    Sci Rep; 2021 Aug; 11(1):16243. PubMed ID: 34376787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate tumor RON receptor signaling mediates macrophage recruitment to drive androgen deprivation therapy resistance through Gas6-mediated Axl and RON signaling.
    Brown NE; Jones A; Hunt BG; Waltz SE
    Prostate; 2022 Nov; 82(15):1422-1437. PubMed ID: 35860905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-androgen therapy induces transcriptomic reprogramming in metastatic castration-resistant prostate cancer in a murine model.
    Zhao Y; Peng X; Baldwin H; Zhang C; Liu Z; Lu X
    Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166151. PubMed ID: 33892077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin Inhibits Androgen Receptor Splice Variant-7 (AR-V7)-Induced Nuclear Factor-Kappa B (NF-κB) Activation and NF-κB Activator-Induced AR-V7 Expression in Prostate Cancer Cells: Potential Implications for the Use of Melatonin in Castration-Resistant Prostate Cancer (CRPC) Therapy.
    Liu VWS; Yau WL; Tam CW; Yao KM; Shiu SYW
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28561752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of ubiquitin ligases in castration-resistant prostate cancer.
    Qi J; Fan L; Hussain A
    Curr Opin Oncol; 2015 May; 27(3):172-6. PubMed ID: 25811345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative Genomic Analysis of OCT1 Reveals Coordinated Regulation of Androgen Receptor in Advanced Prostate Cancer.
    Takayama KI; Suzuki Y; Yamamoto S; Obinata D; Takahashi S; Inoue S
    Endocrinology; 2019 Feb; 160(2):463-472. PubMed ID: 30649323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5.
    Gu P; Chen X; Xie R; Han J; Xie W; Wang B; Dong W; Chen C; Yang M; Jiang J; Chen Z; Huang J; Lin T
    Mol Ther; 2017 Aug; 25(8):1959-1973. PubMed ID: 28487115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hnRNP K⁻AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer.
    Capaia M; Granata I; Guarracino M; Petretto A; Inglese E; Cattrini C; Ferrari N; Boccardo F; Barboro P
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear receptor ERRα contributes to castration-resistant growth of prostate cancer via its regulation of intratumoral androgen biosynthesis.
    Xu Z; Ma T; Zhou J; Gao W; Li Y; Yu S; Wang Y; Chan FL
    Theranostics; 2020; 10(9):4201-4216. PubMed ID: 32226548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9/circMID1/miR-506-3p/MID1.
    Gao F; Xu Q; Tang Z; Zhang N; Huang Y; Li Z; Dai Y; Yu Q; Zhu J
    J Transl Med; 2022 Aug; 20(1):346. PubMed ID: 35918733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the prostate tumour microenvironment II: Impact of hypoxia on a cell model of prostate cancer progression.
    Tonry C; Armstrong J; Pennington S
    Oncotarget; 2017 Feb; 8(9):15307-15337. PubMed ID: 28410543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.